The Supreme Court raised questions regarding the sharp increase in prices for essential anti-cancer medications, labeling this practice as 'daylight robbery' against patients.
These remarks were made after the court was informed that a vital anti-cancer drug has a Maximum Retail Price (MRP) of 27,000 rupees, while its price for retailers (PTR) was only 2,700 rupees, representing a tenfold difference.